Info

RED HOT HEALTHCARE

Welcome to the Red Hot Healthcare show, hosted by Dr. Steve Ambrose. Your go-to podcast for forward-thinking, cutting-edge conversations with today's top healthcare luminaries and business leaders. This shows is not about softball questions or neatly-packaged sales enablement for show guests. It's about bringing the voice of candid thought leaders and forward-thinking visionaries into your mindspace. We cover trends, news, challenges, technology, and opportunities across all segments of the health system. It's for all listeners—healthcare consumers, tech and data leaders, clinical team professionals, policy wonks, life science entrepreneurs, and more. Take a look at our growing list of past show guests—and listen to a few shows. Whether you're on your daily commute, taking a walk, or just looking to learn something new, join us on the Red Hot Healthcare show. Our goal is to inform, inspire, and empower our listners. Want to be a guest? Fill out the guest inquiry form at -- https://redhothealthcare.com/podcast We appreciate our subscribers and thanks for your 5-star reviews!
RSS Feed Subscribe in Apple Podcasts
RED HOT HEALTHCARE
2023
August
July
June
May
April
March


2018
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Feb 14, 2017

“When you can’t beat ‘em – LEAVE ‘EM. That’s the rallying cry and actions, taken by a frustrated, growing group of primary care physicians. 

Today we welcome Dr. Samir Qamar, CEO of MedLion and Michael Tetreault, Editor for the DPC Journal. They’re talking about the emerging movement and benefits of Direct Primary Care. 

Steve has an ear-opening talk with both men about:

  • The basics of a growing movement into the good 'ol days of doctoring
  • Dr. Qamar's unique history
  • The challenges of marketing a DPC practice
  • A growing movement made real with MedLion
  • Providers who fight for patient costs 
0 Comments
Adding comments is not available at this time.